LONDON - Aptamer Group plc (AIM:APTA) has entered into a non-exclusive licensing agreement with Twist Bioscience for the use of its proprietary enzyme-modulating Optimer binder in hot-start PCR and next-generation sequencing (NGS) products, according to a press release issued Tuesday.
The agreement allows Twist Bioscience, a synthetic biology and genomics company, to incorporate Aptamer’s Optimer technology into both existing and future products. Under the terms, Aptamer will supply the Optimer binder directly to Twist Bioscience.
The licensed Optimer binder provides temperature-dependent control for research and assays, with the company noting that in hot-start PCR applications, it eliminates the need for two separate antibody reagents typically required in alternative methods.
This licensing deal represents Aptamer’s first agreement with Twist Bioscience and aligns with the company’s strategy to build a licensing-led revenue model. The financial terms of the agreement were not disclosed in the announcement.
The next-generation sequencing market, where Twist Bioscience has established a position in library preparation, is projected to reach $23.6 billion by 2029, growing at a compound annual growth rate of 13.2%, according to market research cited in the press release.
Dr. Arron Tolley, Chief Executive Officer of Aptamer Group, described the agreement as "a significant step forward" in the company’s licensing strategy and validation of its binders’ commercial potential in the NGS market.
Aptamer Group, based in the UK, develops synthetic binders for the life sciences industry and is listed on the London Stock Exchange’s AIM market.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
ProPicks AI evaluates TWST alongside thousands of other companies every month using 100+ financial metrics. Using powerful AI to generate exciting stock ideas, it looks beyond popularity to assess fundamentals, momentum, and valuation. The AI has no bias—it simply identifies which stocks offer the best risk-reward based on current data with notable past winners that include Super Micro Computer (+185%) and AppLovin (+157%). Want to know if TWST is currently featured in any ProPicks AI strategies, or if there are better opportunities in the same space?